Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
8 Patents
#230 in Boston, MA
#2,098 in Massachusetts
#35,924 in US
Karuna Therapeutics, Inc.
Forward Citations = 14
16 inventors:
Boston, MA, United States of America
Karuna Therapeutics, Inc.
EPO Patents = 1
Trademarks = 4
Forward Citations = 14
Loading Chart...
Loading Chart...
16 inventors (with patents filed for the assignee):
Bruce Rehlaender (6 out of 7 patents)
Aimesther Betancourt (6 out of 9 patents)
Roch Thibert (6 out of 8 patents)
4. James Allen Monn (2 out of 35 patents)
5. Kevin Matthew Gardinier (1 out of 5 patents)
6. Clifford Adam Schlecht (1 out of 1 patent)
7. Dennis A Bennett (1 out of 1 patent)
8. Giorgio Attardo (1 out of 1 patent)
9. James E Audia (1 out of 99 patents)
10. Emanuela Gancia (1 out of 1 patent)
11. Elizabeth Anne Skidmore (1 out of 1 patent)
12. Niall Wagstaff (1 out of 1 patent)
13. Fabien Jean Ghislain Roussel (1 out of 1 patent)
14. Jason Myers (1 out of 1 patent)
15. Nadia M Ahmad (1 out of 1 patent)
8 patents:
Company Overview
Karuna Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for schizophrenia and other central nervous system disorders. The company's lead product candidate, KarXT, aims to target muscarinic receptors to address the cognitive and negative symptoms of schizophrenia. Karuna Therapeutics is dedicated to improving the lives of patients with severe neuropsychiatric disorders through its research and development efforts.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Karuna Therapeutics, Inc.. Retrieved from https://idiyas.com/company/karuna-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]